Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics (NTLA) Misses Q2 EPS by 38c

August 5, 2021 8:21 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q2 EPS of ($1.01), $0.38 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $11.89 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More